NCT05739019
Completed
Not Applicable
A Prospective Observational Study of the Impact of a Recent Past COVID-19 Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles
ShangHai Ji Ai Genetics & IVF Institute1 site in 1 country820 target enrollmentFebruary 23, 2023
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Enrollment
- 820
- Locations
- 1
- Primary Endpoint
- live birth rate
- Status
- Completed
- Last Updated
- 11 months ago
Overview
Brief Summary
This is a prospective observational study. In this study, we aim to investigate the effect of a recent past Covid-19 infection on the live birth rate in the frozen embryo transfer cycles
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women aged 20-42 years at the time of ovarian stimulation for in vitro fertilization
- •Women have embryos frozen prior to COVID infection.
Exclusion Criteria
- •Previous COVID infection before oocyte retrieval
- •Recipient of oocyte donation
- •Undergoing preimplantation genetic testing
- •Presence of hydrosalpinx or endometrial polyp which is not surgically treated
Outcomes
Primary Outcomes
live birth rate
Time Frame: a live birth after 22 weeks gestation
live birth rate of the frozen embryo transfer cycle (\>22 weeks of gestation)
Secondary Outcomes
- ectopic pregnancy(ectopic pregnancy during 12 weeks gestation)
- serum COVID-19 antibody level(7 days before embryo transfer)
- multiple pregnancy(multiple pregnancy beyond gestation 12 weeks)
- serum hCG level(a blood pregnancy test is performed 14 days after the embryo transfer)
- ongoing pregnancy(viable pregnancy beyond gestation 12 weeks)
- biochemical pregnancy(positive blood pregnancy test not followed by clinical pregnancy during 12 weeks gestation)
- miscarriage(the loss of a pregnancy before 22 weeks gestation)
- birth weight(a live birth after 22 weeks gestation)
- implantation rate(number of gestational sacs per embryo transferred during 4 weeks of pregnancy)
- clinical pregnancy(presence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world EvaluationLung Diseases, InterstitialNCT04702893Boehringer Ingelheim108
Completed
Not Applicable
Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in GreeceChoroidal NeovascularizationMacular DegenerationNCT02821247Bayer119
Recruiting
Not Applicable
A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 ImmunotherapyImmunotherapyADRNCT05669638Xuanwu Hospital, Beijing80
Recruiting
Not Applicable
A prospective observational study to investigate real-world IMmunogenicity of theraPeutic Antibodies and to identify faCTors responsible for the interindividual variabilityJPRN-jRCT1011220023Fukudo Masahide300
Completed
Not Applicable
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid ArthritisRheumatoid ArthritisNCT00267852Wyeth is now a wholly owned subsidiary of Pfizer152